Towards Development of New Arthritis Drugs
Modern Biosciences plc has signed an exclusive worldwide license agreement with the University of Aberdeen in order to further develop new treatments for rheumatoid arthritis (RA) and to put into trials the new RA drugs that Aberdeen has discovered but haven’t been tested yet.
Rheumatoid arthritis is a debilitating disease that causes inflammation of the joints which affects some 1% of the worldwide population (or approximately 165 million people. More →
I would like the patients to understand their condition better in order to help them discern what is best for their life with arthritis in conjunction to what their doctors are telling them! .. 
![PetLvr - [The Blog]](http://s3.amazonaws.com/PerfAds_Images/2_26_1214086206_banner_PetLvr_125x125.jpg)
